El CRAI romandrà tancat del 24 de desembre de 2025 al 6 de gener de 2026. La validació de documents es reprendrà a partir del 7 de gener de 2026.
El CRAI permanecerá cerrado del 24 de diciembre de 2025 al 6 de enero de 2026. La validación de documentos se reanudará a partir del 7 de enero de 2026.
From 2025-12-24 to 2026-01-06, the CRAI remain closed and the documents will be validated from 2026-01-07.
 
Carregant...
Miniatura

Tipus de document

Article

Versió

Versió acceptada

Data de publicació

Tots els drets reservats

Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/220267

Optimal linker length for small molecule PROTACs that selectively target p38α and p38β for degradation

Títol de la revista

Director/Tutor

ISSN de la revista

Títol del volum

Resum

We report the design of hetero-bifunctional small molecules that selectively target p38α and p38β for degradation. These proteolysis targeted chimeras (PROTACs) are based on an ATP competitive inhibitor of p38α and p38β, which is linked to thalidomide analogues to recruit the Cereblon E3 ubiquitin ligase complex. Compound synthesis was facilitated by the use of a copper catalyzed 'click' reaction. We show that optimization of the linker length and composition is crucial for the degradation-inducing activity of these PROTACs. We provide evidence that these chemical compounds can induce degradation of p38α and p38β but no other related kinases at nanomolar concentrations in several mammalian cell lines. Accordingly, the PROTACs inhibit stress and cytokine-induced p38α signaling. Our compounds contribute to understanding the development of PROTACs, and provide a useful tool to investigate functions of the p38 MAPK pathway and its involvement in diseases.

Matèries (anglès)

Citació

Citació

RIERA I ESCALÉ, Antoni, DONOGHUE, Craig, CUBILLOS ROJAS, Mónica, GUTIERREZ PRAT, Núria, SÁNCHEZ ZARZALEJO, Carolina, VERDAGUER I ESPAULELLA, Xavier, NEBREDA, Àngel r.. Optimal linker length for small molecule PROTACs that selectively target p38α and p38β for degradation. _European Journal of Medicinal Chemistry_. 2020. Vol. 201, núm. 112451. [consulta: 24 de desembre de 2025]. ISSN: 0223-5234. [Disponible a: https://hdl.handle.net/2445/220267]

Exportar metadades

JSON - METS

Compartir registre